Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000792196 | SCV000931476 | benign | Nemaline myopathy 2 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001552665 | SCV001773396 | uncertain significance | not provided | 2020-08-26 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect |
Ce |
RCV001552665 | SCV004154118 | uncertain significance | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001552665 | SCV004235562 | uncertain significance | not provided | 2023-03-31 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000792196 | SCV002084077 | uncertain significance | Nemaline myopathy 2 | 2020-02-21 | no assertion criteria provided | clinical testing |